DIVINHEALSimplifying Global Wellbeing
Home
Treatments
Hospitals
Doctors
Page background

Immunotherapy & CAR-T Cell Therapy Treatment in Mumbai for Iraq

About

Immunotherapy & CAR-T Cell Therapy in Mumbai for Iraq Patients | Costs & Hospitals

For patients in Iraq facing complex cancer diagnoses, finding advanced treatment options like Immunotherapy and CAR-T Cell Therapy can feel overwhelming. Concerns about treatment quality, access to expertise, and overall cost often add to the emotional burden.

Many seek care beyond their borders, and Mumbai stands out as a leading destination. The city offers world-class oncology centers specializing in these innovative therapies, providing a focused environment for highly specialized care.

Mumbai's medical infrastructure is built on experienced oncology teams and state-of-the-art facilities. Patients benefit from coordinated care, allowing for smoother transitions from initial consultation to advanced treatment and essential follow-up.

Could Mumbai be the right choice for your Immunotherapy or CAR-T Cell Therapy journey?

What is Immunotherapy and CAR-T Cell Therapy?

Immunotherapy and CAR-T Cell Therapy represent cutting-edge approaches in cancer treatment that harness the body's own immune system. Immunotherapy works by boosting or modifying the immune system to recognize and attack cancer cells. This can involve drugs that remove "brakes" on immune cells (checkpoint inhibitors) or introduce lab-made antibodies. CAR-T Cell Therapy is a more personalized immunotherapy where a patient’s T-cells are genetically engineered in a lab to produce chimeric antigen receptors (CARs). These CARs allow the T-cells to identify and destroy specific cancer cells when reinfused into the patient. Both aim to provide highly targeted and often more effective treatment with fewer side effects than traditional chemotherapy.

What Kinds of Immunotherapy & CAR-T Cell Therapy are Available?

Checkpoint Inhibitors (Immunotherapy)

These drugs block proteins that prevent immune cells from attacking cancer, essentially releasing the "brakes" on the immune system.

Monoclonal Antibodies (Immunotherapy)

Lab-produced antibodies that target specific cancer cell proteins, marking them for destruction by the immune system or directly interfering with their growth.

Oncolytic Viruses (Immunotherapy)

Viruses engineered to infect and destroy cancer cells while leaving healthy cells unharmed, also stimulating an immune response against the tumor.

CAR-T Cell Therapy for B-cell Leukemias and Lymphomas

Currently, the most established application involves modifying a patient's T-cells to target specific markers on B-cell cancers, leading to profound responses.

Investigational CAR-T Cell Therapies

Research continues into CAR-T therapies for solid tumors and other hematologic malignancies, expanding the potential reach of this advanced treatment.

When is Immunotherapy or CAR-T Cell Therapy Required?

  • Advanced melanoma that has spread or cannot be removed surgically.
  • Non-small cell lung cancer, especially when traditional treatments have not been effective.
  • Kidney cancer (renal cell carcinoma) that has metastasized.
  • Bladder cancer that is advanced or recurrent.
  • Head and neck squamous cell carcinoma in later stages.
  • Hodgkin lymphoma and non-Hodgkin lymphoma, particularly diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) after other therapies fail.
  • Certain types of acute lymphoblastic leukemia (ALL) in children and young adults, or relapsed/refractory cases.
  • Some types of liver cancer and gastrointestinal cancers when other options are limited.

What Pre-Treatment Evaluation is Needed?

  • Comprehensive medical history review and physical examination.
  • Advanced imaging studies such as PET CT scans or MRI to accurately stage the cancer.
  • Biopsy and pathological review, often including molecular and genetic testing of tumor tissue.
  • Blood tests including complete blood count, kidney function, liver function, and viral screenings.
  • Cardiac evaluation, including echocardiogram or ECG, to assess heart health.
  • Lung function tests (PFTs) to evaluate respiratory capacity.
  • Bone marrow aspiration and biopsy, especially for blood cancers.
  • Discussion with a multidisciplinary tumor board to confirm the treatment plan.

How are These Therapies Performed?

The specific procedure for Immunotherapy and CAR-T Cell Therapy varies based on the type of therapy, cancer condition, and individual patient plan.

Immunotherapy Administration

Immunotherapy drugs are typically given intravenously (IV) through a vein. This process usually takes place in an outpatient clinic or hospital infusion center. The frequency and duration of infusions depend on the specific drug and treatment protocol, ranging from once every few weeks to several months.

CAR-T Cell Therapy Process

This advanced therapy involves several key steps. First, blood is collected from the patient through a process called leukapheresis, similar to donating blood, to harvest T-cells. These T-cells are then sent to a specialized lab where they are genetically modified to express CARs that target cancer cells. After modification and expansion, millions of these CAR-T cells are frozen and sent back to the hospital. Before reinfusion, the patient typically undergoes a short course of chemotherapy to reduce existing immune cells. Finally, the modified CAR-T cells are infused back into the patient, usually requiring hospitalization for close monitoring due to potential side effects.

What Does Recovery Entail?

Recovery from Immunotherapy is often gradual, with side effects managed through medication and monitoring. Patients can usually return to daily activities relatively quickly, but ongoing fatigue or other immune-related side effects might persist. For CAR-T Cell Therapy, the initial recovery involves a hospital stay of several weeks, crucial for monitoring severe side effects like cytokine release syndrome (CRS) or neurotoxicity. After hospital discharge, patients require close outpatient follow-up for several months, often involving weekly appointments. Long-term follow-up is essential to monitor for relapse, manage late-onset side effects, and ensure ongoing well-being. Rehabilitation and supportive care are often integrated into the recovery plan.

What Are the Risks and Success Rates?

  • Immune-related adverse events, such as inflammation in various organs (skin, gut, lungs, endocrine glands).
  • Cytokine Release Syndrome (CRS), a systemic inflammatory response, particularly with CAR-T Cell Therapy, causing fever, low blood pressure, and organ dysfunction.
  • Neurological toxicities (ICANS) post-CAR-T therapy, including confusion, seizures, or language difficulties.
  • Infections due to a weakened immune system or low blood cell counts following treatment.
  • Fatigue, nausea, diarrhea, or skin rashes are common side effects.
  • Long-term effects on organ function or secondary cancers, though rare, are possible.

The success rates for Immunotherapy and CAR-T Cell Therapy vary widely based on the type of cancer, its stage, the patient’s overall health, and prior treatments. For certain leukemias and lymphomas, CAR-T Cell Therapy can achieve complete remission rates of 40-70% in patients who have exhausted other options. Immunotherapy has also shown remarkable, durable responses in various advanced cancers, extending survival significantly for a subset of patients. Outcomes are influenced by how the individual's immune system responds to the therapy, and ongoing research aims to further improve these results and predict patient responses more accurately.

Cost of Immunotherapy & CAR-T Cell Therapy in Mumbai

The cost of Immunotherapy and CAR-T Cell Therapy in Mumbai can vary significantly. Factors influencing the total expenditure include the specific type of therapy chosen, the duration of treatment, the hospital's infrastructure and reputation, the specialist's fees, and the need for additional supportive care or management of side effects. Diagnostic tests, hospital stay duration, and post-treatment medications also contribute to the overall cost.

A broad estimate for Immunotherapy could range from INR 4,00,000 to INR 25,00,000+ per cycle, while CAR-T Cell Therapy typically starts from INR 2,00,00,000 to INR 4,00,00,000+ (approximately 240,000 to 480,000 USD) for the entire procedure, depending on the specific product and patient needs.

Mumbai vs. Global Cost Comparison for Advanced Cancer Therapies

Mumbai offers a significantly more affordable option for Immunotherapy and CAR-T Cell Therapy compared to many Western countries, often without compromising on quality or advanced technology.

Location Immunotherapy (per cycle) CAR-T Cell Therapy (full procedure)
Mumbai, India $5,000 - $30,000 $240,000 - $480,000
United States $15,000 - $50,000+ $500,000 - $1,000,000+
United Kingdom $10,000 - $40,000 $350,000 - $700,000
Germany $8,000 - $35,000 $300,000 - $600,000
Singapore $7,000 - $30,000 $280,000 - $550,000

Comprehensive Assistance for International Patients

  • Support with medical visa applications and extensions.
  • Arrangements for comfortable accommodation during your stay in Mumbai.
  • Assistance with airport transfers and local transportation.
  • Language interpretation services to ensure clear communication with medical staff.
  • Scheduling of all medical appointments, tests, and consultations.
  • Guidance on local culture and amenities to make your stay easier.
  • Assistance with post-treatment follow-up planning, including remote consultations.

Essential Papers for Your Medical Visit

  • A valid passport with sufficient validity for your intended stay.
  • A valid medical visa for India (or proof of application).
  • All relevant past medical reports, including diagnosis, treatment history, and imaging scans.
  • Referral letters from your primary physician or oncologist in Iraq.
  • Proof of funds or insurance coverage for your medical expenses.
  • A list of all current medications, including dosages.
  • Contact details for your emergency contacts.

Preparing for Your Immunotherapy or CAR-T Journey

  • Ensure all necessary medical evaluations and tests are completed as advised by your Mumbai medical team.
  • Arrange for your travel and accommodation in Mumbai well in advance.
  • Inform your treating physician about any current medications, supplements, or allergies you have.
  • Follow any dietary or activity restrictions provided before your treatment.
  • Plan for a support person to accompany you, especially for CAR-T Cell Therapy, given the intensive monitoring required.
  • Understand the treatment plan and potential side effects through detailed discussions with your doctors.

Guidance for Aftercare and Recovery

  • Adhere strictly to all prescribed medications and follow-up schedules.
  • Monitor for any signs of side effects and report them immediately to your medical team.
  • Maintain good hygiene practices to minimize the risk of infection.
  • Follow dietary recommendations and engage in gentle physical activity as advised.
  • Attend all scheduled post-treatment consultations, whether in-person or via telehealth.
  • Ensure you have a reliable local support system for the initial recovery phase in Mumbai.
  • Plan for sufficient rest and avoid strenuous activities during your recovery period.

Seeking Advanced Cancer Treatment in Mumbai?

Our patient support team is ready to assist you. Get a personalized cost estimate and connect with leading oncology specialists in Mumbai.

Take Your Next Step Toward Hope and Healing

Considering Immunotherapy or CAR-T Cell Therapy in Mumbai for cancer treatment is a significant decision. Accessing world-class care and advanced therapies could open new avenues for your health.

Have Questions or Need Expert Guidance?

Reach out to us for a free consultation. Let us help you navigate your treatment options and make informed choices for your health journey.

Hospitals Offering this treatment

India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.

Meet Our Doctors

Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.

Dr. Shelly Mittal

Dr. Shelly Mittal

Sr. Consultant

Medical Oncology & Hematology

New Delhi

14+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Hari Goyal

Dr. Hari Goyal

Director

Medical Oncology & Haemato-Oncology

New Delhi

34+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details

Related Links

هل أنت مستعد لبدء رحلتك العلاجية؟

احصل على خيارات علاجية شخصية من أفضل مستشفيات الهند. خبراؤنا الطبيون جاهزون لمساعدتك في كل خطوة.